MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. - sprookjes - yvandenbroek - TriplyDB

MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.

MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.

http://www.wikidata.org/entity/Q30412320

about

Adoptive T-Cell Immunotherapy Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.Genetically modified T cells in cancer therapy: opportunities and challenges Tumor neoantigens: building a framework for personalized cancer immunotherapy The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry.Peptide Sequence Analysis by Electron Transfer Dissociation Mass Spectrometry: A Web-Based Tutorial.MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.Extended O-GlcNAc on HLA Class-I-Bound Peptides.HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).Charting Immune Signaling Proteomes En Route to New Therapeutic Strategies.Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer.Harnessing shared antigens and T-cell receptors in cancer: Opportunities and challenges Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD).The role of dendritic cells in graft-versus-tumor effect Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen.A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.Building proteomic tool boxes to monitor MHC class I and class II peptides.The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy.Neoepitopes as cancer immunotherapy targets: key challenges and opportunities.Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.Human Tumor Antigens Yesterday, Today, and Tomorrow.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.Human Tumor Antigens and Cancer Immunotherapy.The SysteMHC Atlas project.Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy.The Role of Electron Transfer Dissociation in Modern Proteomics.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction.Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.Immune complexome analysis reveals the specific and frequent presence of immune complex antigens in lung cancer patients: A pilot study.

P2860

Q26782845-4A5E9E07-2259-4C21-99C0-FD6B7B4700D7 Q26796314-BC692446-B934-4C67-B4D2-4815183624BD Q27026627-55D3E0E1-7EE9-489E-A535-988406353EE0 Q28082704-D4DF7EF9-E53E-4E45-A224-AF94A62D7521 Q30252521-DE1002FA-8433-42E5-A07C-F3C3DB5E7053 Q30252783-3F2D90BB-71A7-49C7-B89C-805258C5A885 Q30252929-0E7A6BD9-57D5-4049-85E8-08830A7735E0 Q30278896-820860E3-75FD-4B5E-B485-C05EE1839F66 Q30300282-82BE9B5A-157C-4592-A85E-35492FA0BB01 Q30303138-C0EED4B1-64FC-49A7-961E-471A31AB8954 Q30356689-682A484D-2E6C-4837-A3C6-28AB94DEFE6D Q34985471-8DED0F8B-714F-40B9-973F-E6069FA21A71 Q35815990-13D3B3EE-CE12-4559-9ECB-7BB92809A3FC Q36604367-C98462C5-CA32-4750-BC80-23BA5D05D4CB Q37029731-C1EF9D41-3A17-453D-AF13-95DF40F8C880 Q37126636-38CB9D1F-75E4-44FB-A392-E0880C4474B1 Q37261700-AD70DBBE-19CF-4680-ACEF-B52E636C1BC1 Q37674253-BEC1D6E9-9409-479D-98C6-16D23A07A54D Q38193807-E8AA78B2-7409-4ECE-AB4B-27D7276A00C2 Q38218786-FE5FE863-8919-4E75-B6A3-6B03D1949DA2 Q38704265-E87A2383-C627-46C7-B667-D3816D7B7074 Q38727506-5A3C64CB-0FDB-44DC-B566-1B8D3C022170 Q38753386-C245DDA9-BBB6-4EFF-AC86-14808445FA9C Q39032610-E8698B62-0144-4C84-B4B0-D13BC107E20B Q39115858-43576EA7-CE37-4624-AB8C-1DCA7BF5AF20 Q39183391-694FCFBF-0BEE-4A1C-910E-370836FCA3F2 Q39243052-49795320-9C07-4B78-9EE1-164E67EDE91D Q39279256-4E2D8AFA-9E88-4462-8AA6-020D765C85B7 Q39313889-F99B6383-73C1-4DB8-8047-AE55712FB730 Q40089040-4EC87A1E-DC5C-498E-8EF7-927F99A5DCD2 Q41428789-DFD7BC9D-CFB5-4EB1-A3E7-3A888BED8F2B Q41533232-15978BB1-EBD3-4FE7-B457-A34F9DAB02F6 Q41990341-D0352B66-8FB4-45CF-AE8E-610A485C3C26 Q42143897-ED369195-137A-485D-A5BA-7AA71AD0361C Q44976497-E2822E39-B1A0-451A-9504-1276C03899BB Q47111216-68D68184-57E0-493F-B9CE-9C40C38518F2 Q47133741-B35CB4FC-C902-4449-A4A5-DFD98D844E61 Q47190955-90F09004-E2F8-4113-86B3-A46FC6E8AA00 Q49586408-261BEE50-CB6E-4307-A559-6C0202532309 Q51150531-1729B6FD-E42C-482F-9B8D-BE6BB0612561

P2860

MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.

http://www.wikidata.org/entity/Q30412320

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

MHC class I-associated phospho ...... ory-like immunity in leukemia.

@ast

MHC class I-associated phospho ...... ory-like immunity in leukemia.

@en

type

label

MHC class I-associated phospho ...... ory-like immunity in leukemia.

@ast

MHC class I-associated phospho ...... ory-like immunity in leukemia.

@en

prefLabel

MHC class I-associated phospho ...... ory-like immunity in leukemia.

@ast

MHC class I-associated phospho ...... ory-like immunity in leukemia.

@en

P1433

Q30412320-BEB40824-97D0-4507-B009-19AD6580EFB1

P1476

Q30412320-F418F2CF-7C75-48C5-AB87-D5161C4F66E9

P2093

Q30412320-21BF44A1-9D40-4D7A-B81A-BE310181BF72

Q30412320-2C36DCB9-E7F6-4DF6-AE05-CEF6493D2364

Q30412320-332F2CD9-DFFC-419D-B4F7-571FF32E65F4

Q30412320-3B6B097E-3B44-488D-BB60-F2E66F171907

Q30412320-3C8E288E-DBB8-4481-B460-14AA7598EE68

Q30412320-4EFB0C4B-18E0-4491-AC44-4F08CEDDCA12

Q30412320-55494A56-20F6-43E8-8238-2B018D20BC77

Q30412320-61597B3D-656F-4F20-B574-8798DE382486

Q30412320-6FB2ABD7-15BE-45C0-B02A-18F98CE7DF78

Q30412320-7D4D70A7-3ACB-4048-8FF3-57828CD4FF70

P2860

Q30412320-009E4C65-A045-4D4E-8E53-879DCA42F79C

Q30412320-0245569D-3D14-4F63-AD87-70F1DD1B65AE

Q30412320-0D9B9E43-CC15-4E6E-9109-6B3715D14EA1

Q30412320-0E59BE2D-BCEE-4739-AF64-15BFCF9A4B71

Q30412320-1B51D942-C1FF-47DF-B6F0-490EA880D9BE

Q30412320-1F04B207-FC53-4858-9966-54EF13DC7B68

Q30412320-27ADAD1B-F0A6-4EC6-B29F-276F62032E8C

Q30412320-2D942816-7A5B-4C00-8989-1C2062F134DD

Q30412320-357F49E5-ADEE-4159-864E-B825A9A1A94F

Q30412320-372748BE-F11D-4E12-88C0-1AFB4AD6FCE8

P304

Q30412320-C560D3CE-421D-4256-94BD-B8F9479F3C36

P31

Q30412320-F2E09BC0-5DEA-4277-A385-A58C926CF08F

P356

Q30412320-702821DE-D5C6-4CA5-A49B-E2535EF0B2AF

P407

Q30412320-CB09116D-C530-47BF-B62D-1454A0DC41E4

P433

Q30412320-68AA4F11-24CC-4B71-8F5A-F7C0C0170FC6

P478

Q30412320-70126A0C-F9A7-45D8-800B-27A539542869

P50

Q30412320-247AA4F5-30CF-4D8D-AE4D-F88EE3631C41

Q30412320-3BB1053D-1345-40EE-8788-6F82B7633577

Q30412320-B5EFBD3E-A681-428B-BB55-E57116C8A39B

Q30412320-BD3C92F5-46FD-4A98-B244-103FCAC06FDF

Q30412320-C4D370D0-B2A5-4DD1-A4A0-BC53E5993085

P577

Q30412320-5E2070E9-332B-49D4-91C2-33323A00C1C0

P5875

Q30412320-AB837DC9-6CFD-4DB4-B330-04DDBD25E1EA

P698

Q30412320-A4D15DBF-DDBE-4C21-944F-9E10C95C1B51

P921

Q30412320-5B27A92B-75AD-4849-AC10-8DF320E0A056

P932

Q30412320-AA813485-ED63-4BB1-94C9-10A779A51B9C

P356

SCITRANSLMED.3006061

P1433

Science Translational Medicine

P1476

MHC class I-associated phospho ...... mory-like immunity in leukemia

@en

P2093

Andrew Norris

http://www.w3.org/2001/XMLSchema#string

Angela L Zarling

http://www.w3.org/2001/XMLSchema#string

Ann Michelle English

http://www.w3.org/2001/XMLSchema#string

Donald F Hunt

http://www.w3.org/2001/XMLSchema#string

Guy Pratt

http://www.w3.org/2001/XMLSchema#string

Hsing-Wen Huang

http://www.w3.org/2001/XMLSchema#string

Hugo De La Peña

http://www.w3.org/2001/XMLSchema#string

Jeffrey Shabanowitz

http://www.w3.org/2001/XMLSchema#string

Jennifer Cottine

http://www.w3.org/2001/XMLSchema#string

Jennifer G Abelin

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73

Cancer immunotherapy: moving beyond current vaccines

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry.

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

BRAF mutations in hairy-cell leukemia

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

P304

203ra125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3006061

http://www.w3.org/2001/XMLSchema#string

P407

P433

203

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Victor H Engelhard

Charles Craddock

Stacy A Malaker

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256764083

http://www.w3.org/2001/XMLSchema#string

P698

24048523

http://www.w3.org/2001/XMLSchema#string

P921

P932

4071620

http://www.w3.org/2001/XMLSchema#string